Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: MAIA Biotechnology Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
MAIA Biotechnology Inc. May 25, 202398.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | TransUnion | Open-market sale | −1,000 | $77.74 | $77,740 |
| Oct 15, 2026 | TransUnion | Open-market sale | −1,000 | $70.00 | $70,000 |
| Sep 1, 2026 | TransUnion | Open-market sale | −1,000 | $84.42 | $84,420 |
| Aug 28, 2026 | TransUnion | Shares withheld for tax | −8,018 | $85.67 | $686,902 |
| Aug 3, 2026 | TransUnion | Open-market sale | −1,000 | $79.96 | $79,960 |
| Jul 1, 2026 | TransUnion | Open-market sale | −10,000 | $72.64 | $726,400 |
| Jun 1, 2026 | TransUnion | Open-market sale | −5,000 | $70.73 | $353,650 |
| May 18, 2026 | TransUnion | Shares withheld for tax | −16,063 | $68.60 | $1,101,922 |
| May 12, 2026 | TransUnion | Grant or award | +36,258 | — | — |
| May 1, 2026 | TransUnion | Open-market sale | −5,000 | $71.93 | $359,650 |
| Apr 2, 2026 | TransUnion | Open-market sale | −5,000 | $70.00 | $350,000 |
| Mar 2, 2026 | TransUnion | Open-market sale | −5,000 | $76.64 | $383,200 |
| Feb 27, 2026 | TransUnion | Grant or award | +24,825 | — | — |
| Feb 27, 2026 | TransUnion | Shares withheld for tax | −10,627 | $78.55 | $834,751 |
| Feb 10, 2026 | TransUnion | Grant or award | +23,921 | — | — |
Questions about Steven M. Chaouki
What boards is Steven M. Chaouki on?
Steven M. Chaouki sits on the board of MAIA Biotechnology Inc.
How long has Steven M. Chaouki served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.